Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease

Figure 1 Visceral fat measurement by bioimpedanciometry, according to histological fibrosis stage. A: Visceral fat measurements increased along with fibrosis stage assessed by histological analysis (F0-1, 12; F2-3, 14; F4, 16; Kruskal-Wallis ^cP < 0.001). A line can be fit by linear regression, showing linear association (r² = 0.11, ^cP < 0.001); B: Visceral fat measurements were greater for those patients with significant fibrosis (16.3 vs 13.1, ^cP < 0.001).